NCT05943249

Brief Summary

Using magnetic resonance (MR) imaging or spectroscopy as part of clinical research typically involves developing new MR protocols. Although some of this work is done by scanning artificial 'phantoms', volunteer studies are normally needed to configure and validate new protocols appropriately. Developing new MR protocols and techniques is also useful in its own right. The volunteer scanning described in this application will provide data to support this type of methodological research into new scanning and image processing techniques: improving the speed, quality, and range of measurements possible with the scanner. With proper safety and screening procedures, MR has no known side-effects, and has been performed on millions of human subjects worldwide without ill effect. There are well-established contraindications for MRI, and screening procedures are already in place in the MR unit at UCLH to exclude such subjects and ensure the safety of subjects. With these, and the MR scanner's built in safety mechanisms, residual risk is low. Many other trusts with active MR research have previously made similar applications to this related to volunteer MR scanning for pilot work and methodological research Although scans may obtained as part of several research projects, in each case it is only the scanning technique (the programmed sequence of data acquisition and processing steps) which will vary, along with the body region to be imaged. The volunteer experience will be very similar, and all ethical issues, including the information sheet and consent form, will be identical. These scans are for methodological research on the MR techniques themselves, and will be never form part of the volunteer's own healthcare. Separate ethical permission is sought for any study which does not match the above criteria.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started Jun 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Jun 2007Nov 2028

Study Start

First participant enrolled

June 4, 2007

Completed
16.1 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 13, 2023

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2028

Last Updated

December 10, 2024

Status Verified

December 1, 2024

Enrollment Period

21.5 years

First QC Date

June 26, 2023

Last Update Submit

December 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Development of novel MR techniques

    New protocols will be developed and validated to be used in clinical research, and to provide volunteer data for ongoing research into magnetic resonance techniques: improving the speed, quality, and range of measurements possible with the scanner.

    1 year

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participant with the relevant condition Participant without condition Pre-condition Professionals Carers Relations Other Diagnostic, screening or prevention participants Genetically predisposed

You may qualify if:

  • Healthy volunteers will be recruited by email from within departments at UCL and UCLH
  • male or female
  • Aged 18 and above

You may not qualify if:

  • volunteers with pacemakers or other implanted devices, or with other metallic foreign bodies, will be excluded.
  • Women who may be pregnant
  • any participants who cannot give informed consent (including anyone who may not adequately understand the verbal explanations or written information given in English)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University College London

London, United Kingdom

RECRUITING

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Central Study Contacts

Neela Ramchurn

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2023

First Posted

July 13, 2023

Study Start

June 4, 2007

Primary Completion (Estimated)

November 30, 2028

Study Completion (Estimated)

November 30, 2028

Last Updated

December 10, 2024

Record last verified: 2024-12

Locations